Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease

This publication has 15 references indexed in Scilit:

• Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation
  Biochemical Journal, 2003
• The role of the iminosugar N‐butyldeoxynojirimycin (miglustat) in the management of type I (non‐neuronopathic) Gaucher disease: A position statement
  Journal of Inherited Metabolic Disease, 2003
• Introduction
  Philosophical Transactions Of The Royal Society B-Biological Sciences, 2003
• Design, Synthesis and Biological Evaluation of Iminosugar-Based Glycosyltransferase Inhibitors
  Current Topics in Medicinal Chemistry, 2003
• Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins
  Biochemical Journal, 2002
• Carbohydrate mimetics-based glycosyltransferase inhibitors
  Bioorganic & Medicinal Chemistry, 2001
• Inhibition of Glycosphingolipid Biosynthesis: Application to Lysosomal Storage Disorders
  Chemical Reviews, 2000
• Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis
  The Lancet, 2000
• Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis
  Tetrahedron: Asymmetry, 2000
• Mutations causing gaucher disease
  Human Mutation, 1994